Чечня: надежность социологических измерений
Published in Journal of Viral Hepatitis • Jan 1, 2004
Authors:
Сергей Романович Хайкин
Abstract
Entecavir 0.5 mg (ETV) is widely used among treatment-naïve chronic hepatitis B (CHB) patients. However, 10%-30% of patients show partial virologic response (PVR) to the drug. If the hepatitis B virus (HBV) continues to replicate, the underlying liver disease may progress. Herein, we compared the ef...
Subject
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!